MARKET

EOLS

EOLS

Evolus
NASDAQ
6.65
-0.02
-0.30%
After Hours: 6.65 0 0.00% 17:19 12/31 EST
OPEN
6.60
PREV CLOSE
6.67
HIGH
6.80
LOW
6.60
VOLUME
1.05M
TURNOVER
--
52 WEEK HIGH
17.12
52 WEEK LOW
5.71
MARKET CAP
431.05M
P/E (TTM)
-7.2885
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR) and Evolus (EOLS)
TipRanks · 12/31/2025 11:40
Evolus CEO David Moatazedi Reports Sale of Common Shares
Reuters · 12/29/2025 23:42
Evolus Inc. Officer Rui Avelar Reports Sale of Common Shares
Reuters · 12/29/2025 23:42
Weekly Report: what happened at EOLS last week (1222-1226)?
Weekly Report · 12/29/2025 10:10
Needham Reiterates Hold on Evolusto Hold
Benzinga · 12/24/2025 11:05
Evolus (EOLS): Maintaining Hold Amid Softer Aesthetic Injectables Demand and Macro Headwinds
TipRanks · 12/23/2025 19:15
Weekly Report: what happened at EOLS last week (1215-1219)?
Weekly Report · 12/22/2025 10:09
Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026
Seeking Alpha · 12/17/2025 21:42
More
About EOLS
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates represent two of the product categories within medical aesthetics, injectable neurotoxins and injectable hyaluronic acid gels. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Jeuveau offers a 900kDa botulinum toxin alternative to BOTOX (onabotulinumtoxinA). Jeuveau is available in the United States, Canada, and certain European markets. Evolysse is a line of hyaluronic acid dermal fillers which utilizes first-generation cold technology. The line includes a variety of products, including mid face, nasolabial folds, lips and eyes in the United States and Europe.

Webull offers Evolus Inc stock information, including NASDAQ: EOLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EOLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EOLS stock methods without spending real money on the virtual paper trading platform.